10/23/2024
3:11 PM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
11:15 PM | Corvus Pharmaceuticals (Filer)
| Form EFFECT | |
08/06/2024
4:31 PM | Corvus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/01/2024
8:18 PM | Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
06/17/2024
5:46 PM | Corvus Pharmaceuticals (Issuer)
Grais Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:48 PM | CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:41 PM | Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:43 PM | Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:44 PM | Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:29 PM | Corvus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
05/08/2024
7:28 PM | Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
7:34 PM | Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:55 PM | Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
05/07/2024
4:16 PM | Corvus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:19 PM | Corvus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024
3:05 PM | Corvus Pharmaceuticals (Filer)
| Form 424B5 | |
05/01/2024
4:06 PM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:57 PM | Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
12:31 PM | Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/13/2024
5:27 PM | Corvus Pharmaceuticals (Subject)
MILLER RICHARD A MD (Filed by)
| Form SC 13G/A | |
